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Background: Immune-mediated myositis (IMM) in American Quarter Horses (QHs) causes acute
muscle atrophy and lymphocytic infiltration of myofibers. Recently, an E321G mutation in a
highly conserved region of the myosin heavy chain 1 (MYH1) gene was associated with suscepti-
bility to IMM and nonexertional rhabdomyolysis.
Objectives: To estimate prevalence of the E321G MYH1 variant in the QH breed and perfor-
mance subgroups.
Animals: Three-hundred seven elite performance QHs and 146 random registered QH controls.
Methods: Prospective genetic survey. Elite QHs from barrel racing, cutting, halter, racing, rein-
ing, Western Pleasure, and working cow disciplines and randomly selected registered QHs were
genotyped for the E321GMYH1 variant and allele frequencies were calculated.
Results: The E321G MYH1 variant allele frequency was 0.034  0.011 in the general QH popu-
lation (6.8% of individuals in the breed) and the highest among the reining (0.135  0.040;
24.3% of reiners), working cow (0.085  0.031), and halter (0.080  0.027) performance sub-
groups. The E321G MYH1 variant was present in cutting (0.044  0.022) and Western Pleasure
(0.021  0.015) QHs at lower frequency and was not observed in barrel racing or racing QHs.
Conclusions and Clinical Importance: Knowing that reining and working cow QHs have the high-
est prevalence of the E321G MYH1 variant and that the variant is more prevalent than the alleles
for hereditary equine regional dermal asthenia and hyperkalemic periodic paralysis in the general
QH population will guide the use of genetic testing for diagnostic and breeding purposes.
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1 | INTRODUCTION
Immune-mediated myositis (IMM) in American Quarter Horses (QHs)
causes recurrent episodes of acute epaxial and gluteal muscle
atrophy.1 Susceptibility to IMM was recently attributed to an E321G
missense mutation in the myosin heavy chain 1 (MYH1) gene encoding
type IIX myosin heavy chain that alters the amino acid composition of
the globular head region, potentially impacting protein stability.2 In
horses carrying this allele, exposure of the novel myosin isoform to
the extracellular environment appears to initiate lymphocytic infiltra-
tion and destruction of predominantly type IIX myofibers.2 More
recently, this same genetic variant was associated with nonexertional
rhabdomyolysis (non-ER) in QHs with or without atrophy and lympho-
cytic infiltrates.3
Abbreviations: AQHA, American Quarter Horse Association; ER, exertional
rhabdomyolysis; GBED, glycogen-branching enzyme deficiency; HERDA, hered-
itary equine regional dermal asthenia; HYPP, hyperkalemic periodic paralysis;
IMM, immune-mediated myositis;MYH1, myosin heavy chain 1; MYHM, myosin
heavy chain 1 myopathies; PCR, polymerase chain reaction; PSSM1, polysac-
charide storage myopathy type 1; SE, standard error; QH, Quarter horse; VGL,
Veterinary Genetics Laboratory; YOB, years of birth.
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Many specialized performance equine subgroups have developed
that utilize predominantly QHs selected for adeptness at sports
ranging from mostly stationary halter horses to extremely fast barrel
and racing animals. Selection for this range of athletic performance
has led to marked population stratification and founder effects within
this breed. Disproportionately high frequencies of certain disease
alleles have therefore occurred in specific purpose-bred subpopula-
tions. For example, there is an overwhelming prevalence of hyperkale-
mic periodic paralysis (HYPP) in horses bred for halter work and a high
prevalence of lethal white foal syndrome in American Paint Horses, a
QH-derived breed bred to have distinct spotted coats.4–9 Thus, it is
possible that IMM, a disorder associated with a gene impacting
the fastest contracting skeletal muscle fibers, could have a higher
prevalence in certain performance QH subtypes.
A thorough understanding of any disease must include charac-
terization of the at-risk population. For genetic disorders, this
involves identifying environmental risk factors, constructing pedi-
grees, and determining disease allele frequencies. For IMM, a recent
infectious respiratory disease, vaccination against certain respiratory
pathogens and rhabdomyolysis appear to be environmental triggers.
Pedigree analysis identified 4 QH stallions that were overrepre-
sented in the lineage of affected horses.1,2,10 A genetic test for the
E321G MYH1 variant is now available, allowing veterinarians to
diagnose IMM and non-ER with ease and providing horse owners
with a tool to make informed breeding decisions and avoid
producing affected foals. To best utilize genetic testing, the preva-
lence of the E321G MYH1 variant in the QH population and specific
performance subgroups must be elucidated. Based on clinical
severity or high breed prevalence, genetic testing for some diseases
(eg, hereditary equine regional dermal asthenia [HERDA], HYPP) is
mandated by the American Quarter Horse Association (AQHA) for
every breeding animal.11
The objective of our study was to estimate the E321G MYH1
variant frequency in the general QH population and in 7 distinct
subpopulations of QHs used for barrel racing, cutting, halter, racing,
reining, Western Pleasure, and working cow horse competitions.
2 | MATERIALS AND METHODS
2.1 | Study design
This was a prospective, genetic study of AQHA-registered horses in
which the authors were blinded to the identity of individual horses.
2.2 | Samples
With permission from the AQHA, the association's animal registration
records were examined to select the study population described
herein. Each horse was assigned a random study ID number by
personnel uninvolved in the genotyping for this project to maintain
animal anonymity. Mane hair samples from each horse were provided
by the Veterinary Genetics Laboratory (VGL), University of California,
Davis, which houses the AQHA's repository of hair samples from all
registered animals.
2.2.1 | Selection criteria for whole-population controls
A random sampling scheme was used to select control QHs for esti-
mating the whole-breed frequency of the E321G MYH1 variant.
Between March 2013 and September 2017, a single week day per
month was randomly selected, and on that date, every 10th QH hair
sample submitted by the AQHA to the VGL for DNA testing was
selected until 40 samples with sufficient hair follicles for subsampling
were available for each year in the sampling period. In total, 200 con-
trols were sampled, and anonymized hair samples were provided.
2.2.2 | Selection criteria for performance horses
The eligibility criteria for elite horses in the 7 performance subgroups
of interest (barrel racing, cutting, halter, racing, reining, Western Plea-
sure, and working cow) were placement in the list of 75 AQHA-
registered horses that had earned the most competition points (halter
discipline) or sport money (all other disciplines) in the United States
between January 1, 2014, and June 15, 2017. Records of sport money
and competition point earnings were obtained from an online records
company12 for all disciplines except racing, for which records were
obtained directly from the AQHA.13
2.3 | Genotyping
Genomic DNA was isolated from each horse’s hair sample using the
Gentra Puregene Tissue Kit (QIAGEN, Germantown, Maryland).
Genotyping was performed by pyrosequencing. Forward, reverse,
and sequencing primers were designed using Pyrosequencing Assay
Design Software V1.0 (Biotage AB, Uppsala, Sweden). Reverse biotin-
labeled and regular forward primers were ordered through Integrated
DNA Technologies, Inc. (Skokie, Illinois). Forward (50-TAAAAAGCTG
CATGTGTA-30) and reverse (50-AAAACACATACCCTGAAT-30) primers
were used to amplify a 159-bp region (ECA11: 52993805-52993946)
containing the site (ECA11: 52993878) of the E321G MYH1 variant.
The resulting amplicon was annealed with the sequencing primer
(50-TGCTGGGGACTGTGA-30), and the relative expression of each
allele was determined by pyrosequencing following manufacturer pro-
tocol using the PyroMark Gold Q96 Kit (QIAGEN). All sample plates
were analyzed using a positive control and no template control, with
the resulting data collated and genotypes inferred and tabulated for
further analysis.
In addition, pyrosequencing results were validated in a subset of
horses using a polymerase chain reaction (PCR) assay and Sanger
sequencing protocol previously described for evaluating the E321G
MYH1 variant in QHs.2 Control and performance horses from our
study were pooled after genotyping by pyrosequencing, and 5 horses
from each MYH1 genotype group (ie, homozygous wild type, hetero-
zygous, and homozygous alternative) were selected by computer
randomization to have their samples used for this validation step.
2.4 | Allele frequency and standard error
calculations
Spreadsheet software14 was used to calculate a basic allele frequency
for the general QH population and each of the 7 performance sub-
groups according to the formula
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fMy ¼
HMy=N + 2HMy=My
2n
,
where My represents the E321G MYH1 variant, N represents the
wild-type MYH1 allele, HX represents the number of horses with
genotype X, and n is the total number of horses in the study popula-
tion for which allele frequency is being calculated. Because multino-
mial sampling schemes were used to select the study populations,
standard error (SE) associated with each allele frequency calculation
was also estimated according to the formula
SEfMy ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
fMy × 1− fMyð Þ
2n
r
:
Chi-square contingency tests were performed using the same
software to determine if the frequency of the E321G MYH1 variant in
each of the performance subgroups was statistically significantly dif-
ferent when compared to the control group.
3 | RESULTS
3.1 | Whole-breed allele frequency
The years of birth (YOB) of control QHs selected to represent the
general population of this breed ranged from 1994 to 2017 (median
YOB = 2013), and the distribution of sexes was slightly female-
skewed (39% male versus 61% female) in this study group. The sam-
pling scheme utilized was assumed to provide fair coverage of the
entire geographic region from which AQHA-registered animals typi-
cally originate (the United States and Canada); however, these data
were not evaluated. Of the 200 control equine hair samples obtained,
a total of 146 high-quality DNA samples were successfully isolated
and genotyped by pyrosequencing. The E321G MYH1 variant fre-
quency (estimated value  SE) in the general QH population was
0.034  0.011 (Table 1), with 10 individuals (ie, 6.8% of the popula-
tion) genotyping as heterozygous for the E321G MYH1 variant and no
homozygotes identified (Figure 1).
3.2 | Allele frequency in performance subgroups
The elite performance QHs utilized in our study had YOB ranging
from 1998 to 2015 (median YOB = 2011). The distribution of elite
males and females within each discipline was approximately equal
(53%-63% male versus 37%-47% female) except for the working cow
and reining disciplines, in which males were overrepresented (76%-
77% male versus 23%-24% female). Because top-performing horses in
a given discipline often share common ancestors from a limited num-
ber of genetic lines with breeding stock residing on a limited number
of farms, potential geographic bias in these samples was considered
irrelevant.
Of the 350 performance equine hair samples obtained, a total of
307 high-quality DNA samples were successfully isolated and geno-
typed by pyrosequencing. The frequency of the E321G MYH1 variant
was the highest in QHs from the reining (0.135  0.040, n = 37),
working cow (0.085  0.031, n = 41), and halter (0.080  0.027,
n = 50) performance subgroups. At α = 0.05, the frequency of the
E321G MYH1 variant in reining horses was statistically significantly
different (P value = 6.5 × 10−4) from the frequency in the control
group, and the difference in variant frequency between controls and
working cow (P value = 5.0 × 10−2) and halter (P value = 6.0 × 10−2)
horses approached significance. Cutting (0.044  0.023, n = 45) and
Western Pleasure (0.021  0.015, n = 48) QHs also carried the
E321G MYH1 variant; however, the difference in variant frequency in
these groups as compared to controls was clearly statistically insignifi-
cant. The E321G MYH1 variant was not observed in either the barrel
TABLE 1 The individualMYH1 genotype counts (N = wild-type allele, My = E321G variant), E321GMYH1 variant frequencies (estimated value
 SE), and P values from chi-square testing in the control group and performance subgroups of QHs
Study group Sample size
Genotype
Frequency P-valueN/N My/N My/My
Control 146 136 10 0 0.034  0.011
Reining 37 28 8 1 0.135  0.040 6.5 × 10−4
Working cow 41 34 7 0 0.085  0.031 5.0 × 10−2
Halter 50 42 8 0 0.080  0.027 6.0 × 10−2
Cutting 45 41 4 0 0.044  0.023 6.5 × 10−1
Western Pleasure 48 46 2 0 0.021  0.015 5.1 × 10−1
Barrel racing 42 42 0 0 NO
Racing 44 44 0 0 NO
Abbreviations: NO, not observed in this study group; QH, Quarter Horse; SE, standard error.
FIGURE 1 The distribution of MYH1 genotypes within the reining
(n = 37), working cow (n = 41), halter (n = 50), cutting (n = 45),
control (n = 146), Western Pleasure (n = 48), barrel racing (n = 42),
and racing (n = 44) QH study groups. Abbreviations: My, E321G
variant; N, wild-type allele; QH, Quarter Horse
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racing (n = 42) or racing (n = 44) QHs in this survey. Allele frequencies
and individual genotype counts in the performance subgroups are
summarized in Table 1. In the most affected performance subgroups,
approximately 24.3% of reiners, 17.1% of working cow horses, and
16.0% of halter horses possessed at least 1 copy of the E321G MYH1
variant, which was present in the homozygous condition in only 1 indi-
vidual from the reining discipline (Figure 1).
3.3 | Validation of genotyping by pyrosequencing
A total of 453 horses were genotyped for the MYH1 variant by pyrose-
quencing in our study, which identified 413 homozygous wild-type indi-
viduals, 39 heterozygotes, and 1 homozygous alternate individual. Five
individuals from each of the pools of homozygous wild-type and het-
erozygous individuals were randomly selected, in addition to the 1 indi-
vidual homozygous for the E321G MYH1 variant, for genotyping by
PCR and Sanger sequencing to validate the results obtained from pyro-
sequencing. There was perfect agreement between the results obtained
by both methods of genotyping in this subset of 11 horses tested.
4 | DISCUSSION
Immune-mediated myositis in American QHs is characterized by auto-
immunity directed at type IIX myofibers, resulting in episodes of
marked muscle atrophy.1,2,15 A missense E321G MYH1 mutation in
the gene that encodes the MYH1 protein found in type IIX myofibers
was found to be responsible for IMM as well as for a codominantly
inherited form of severe acute non-ER in QH-related breeds.2,3 These
2 myopathies have been grouped under the heading of myosin heavy
chain 1 myopathies (MYHM) based on this newly recognized etiol-
ogy.3 The major finding in the present study was the relatively
common occurrence of the E321G MYH1 mutation in QHs. The
whole-breed frequency of the E321G MYH1 variant was 0.034 with a
prevalence in the general population of 6.8% horses. The frequency of
the E321G MYH1 variant in the general QH population (0.034) is
slightly higher than the whole-breed estimates of disease allele
frequencies previously reported for HYPP (0.008) and HERDA (0.021)
but lower than those for type 1 polysaccharide storage myopathy
(PSSM1) (0.055) and glycogen-branching enzyme deficiency (GBED)
(0.054).4 In essence, a random breeding of registered QHs in the
population would produce a foal at greater risk of having the E321G
MYH1 variant and potentially developing MYHM than 2 other
important genetic diseases of this breed (HYPP, HERDA) for which
testing is already mandated by the AQHA. Thus, it will be important
to educate veterinarians, owners, and breeders of QHs about the
genetic basis of MYHM and the relatively common occurrence of the
E321G MYH1 mutations in QHs.
The American QH is a prolific breed, with over 2.8 million AQHA-
registered animals alive worldwide in 2017, and is the most popular
type of horse used in over 14 recognized equestrian sports in the
United States.16 Individual QHs must possess specific and often dispa-
rate characteristics to excel in their respective disciplines (eg, a compact
and heavily muscled body type is ideal for horses used to work
livestock, whereas longer-legged and leaner animals are preferred for
racing and hunter classes). Thus, although American QHs retain a
remarkable level of genetic diversity when considered as a single popu-
lation, the differential selective pressures required to succeed in various
disciplines has led to marked population stratification within the breed.
This has been demonstrated in recent analyses of genetic relatedness
among performance subgroups of QHs, including 6 groups (not includ-
ing barrel racing) examined in the present study of E321G MYH1 vari-
ant frequency.17 Our investigation supports previous suggestions that
it is incorrect to assume without a confirmatory genetic survey that the
frequency of a disease allele in 1 performance subgroup of QHs is
similar to that in a different subgroup or the whole breed.4 On average,
the prevalence of the E321G MYH1 variant was 54% different in
magnitude among the 5 performance subgroups in this survey.
Within the performance subtypes examined in our study, the
E321G MYH1 variant frequency was the highest in reining (0.135),
working cow (0.085), and halter (0.080) horses, making up approxi-
mately 8%-14% of the total copies of MYH1 in those subpopulations.
The frequency of the E321GMYH1 variant was statistically significantly
higher in the reining horses than in the general population of QHs,
approaching a significant difference in the working cow and halter
horses. Cutting (0.44) horses and Western Pleasure (0.021) horses did
not differ significantly in the frequency of the E321G MYH1 variant
compared to the general population. The E321G MYH1 variant was not
observed in the barrel racing or racing horses in this survey. The
absence of the E321G MYH1 variant in barrel racing and racing QHs in
this survey complements previous studies that reported the lowest fre-
quency of disease alleles associated with HYPP, GBED, HERDA, and
PSSM1 in barrel racing QHs versus all other performance subgroups
except racing QHs, which were free of these disease alleles.4 Horses in
these performance subgroups likely have relatively fewer deleterious
alleles because of the larger influence of Thoroughbred bloodlines and
thus greater heterozygosity at important disease loci.4,17 The combina-
tion of performance groups with the highest frequencies of the MYH1
mutation is unique compared to the other genetic disorders of QHs;
GBED, HERDA, HYPP, and PSSM1 have the highest prevalence in hal-
ter, Western Pleasure, and cutting horse populations.4
Our study establishes MYHM as an important genetic disease of
the American QH with a risk allele frequency in the general population
higher than several other genetic diseases in this breed (HYPP and
HERDA). The high frequency of the E321G MYH1 variant in reining
QHs compared to the general population (3.6-fold greater) warrants a
focus on screening breeding stock in this subpopulation for the
E321GMYH1 variant.
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